Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States Clinical research trials and Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States. Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States clinical trial. Human subjects often receive the most effective healthcare possible for their Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "C" Clinical Trials Conditions > Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States

Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States



Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States

For Condition: Chagas Disease,Heart Diseases,Myocardial Diseases
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: A detailed review was made of data pertinent to the occurrence of chronic Chagas disease in the United States.
Details: BACKGROUND: In Latin America, 16 to 18 million individuals are thought to have Chagas' disease and 90 million are considered to be at risk of infection. In the United States, the occurrence of Chagas' disease is virtually limited to individuals who have resided in Latin America where they acquired the infection, and then migrated to this country. DESIGN NARRATIVE: Data on the prevalence of positive serologic reactions for Trypanosoma cruzi (a protozoan causing Chagas cardiomyopathy) serve for calculating that a total of up to 74,000 Latin Americans residing in the United States have the chronic form of chagasic cardiomyopathy. The vast majority of these individuals are either undiagnosed, or misdiagnosed as having idiopathic dilated cardiomyopathy or coronary artery disease. Vector transmission of T. cruzi infection is very unlikely to occur in the United States because of variations in biological behavior of local species of insect vectors and because of changes in human living conditions. Transfusion of blood from infected but asymptomatic individuals is considered the most important mechanism of transmission of this disorder in the United States.
Eligibility:
Study Type:  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: No eligibility criteria
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:  4488; 
Study Start Date: January 1993
Record last reviewed: November 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005455

Other Chagas Disease Studies:
1. Predicting Physical Activity Change: an Epidemiologic Study

2. Apolipoprotein Polymorphisms and Risk of Coronary Heart Disease

3. Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT

4. Family Blood Pressure Program - GENOA

5. Insulin Resistance and Blood Pressure Regulation in Blacks

Related Studies:

Other Chagas Disease Clinical Trials
Other Clinical Trials
Other Clinical Trials

Chagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States
Modify your Search

  Other Chagas Disease Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103